These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34610978)

  • 1. Protecting privacy in mandatory reporting of infectious diseases during the COVID-19 pandemic: perspectives from a developing country.
    Sert G; Mega E; Karaca Dedeoğlu A
    J Med Ethics; 2022 Dec; 48(12):1015-1019. PubMed ID: 34610978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics, Integrity, and Retributions of Digital Detection Surveillance Systems for Infectious Diseases: Systematic Literature Review.
    Zhao IY; Ma YX; Yu MWC; Liu J; Dong WN; Pang Q; Lu XQ; Molassiotis A; Holroyd E; Wong CWW
    J Med Internet Res; 2021 Oct; 23(10):e32328. PubMed ID: 34543228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adaptation of the routine surveillance system for infectious diseases in 2020 in the context of the COVID-19 pandemic].
    Diercke M; Claus H; Rexroth U; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Apr; 64(4):388-394. PubMed ID: 33847762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protecting First Responders While Maintaining Personal Privacy During the COVID-19 Pandemic: One County's Approach.
    Fifolt M; McMahon S; Hoff C; Smith L; Ayala K
    J Public Health Manag Pract; 2023 Sep-Oct 01; 29(5):718-724. PubMed ID: 37097172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Italian Mandatory Notification System: An Important Public Health Tool For Continuous Monitoring Of Infectious Diseases.
    Facciolà A; Visalli G; D’Andrea G; Laganà A; Varvarà M; Spataro P; Di Pietro A
    New Microbiol; 2022 Apr; 45(2):115-123. PubMed ID: 35699560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of Australian policy-makers on the potential benefits and risks of technologically enhanced communicable disease surveillance - a modified Delphi survey.
    Degeling C; Johnson J; Gilbert GL
    Health Res Policy Syst; 2019 Apr; 17(1):35. PubMed ID: 30947721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current ethical and social issues in epidemiology.
    Salerno J; Coughlin SS; Goodman KW; Hlaing WM
    Ann Epidemiol; 2023 Apr; 80():37-42. PubMed ID: 36758845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health. Surveillance and privacy.
    Bayer R; Fairchild AL
    Science; 2000 Dec; 290(5498):1898-9. PubMed ID: 11187045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020-2021: situational analysis.
    Kitamura N; Abbas K; Nathwani D
    BMC Public Health; 2022 May; 22(1):991. PubMed ID: 35578330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of notifiable infectious diseases during the COVID-19 response.
    Stefanoff P; Løvlie AL; Elstrøm P; Macdonald EA
    Tidsskr Nor Laegeforen; 2020 Jun; 140(9):. PubMed ID: 32549020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the shadow of privacy: Overlooked ethical concerns in COVID-19 digital epidemiology.
    Ferretti A; Vayena E
    Epidemics; 2022 Dec; 41():100652. PubMed ID: 36356477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical Challenges Associated with Pathogen and Host Genetics in Infectious Disease.
    Milne R; Patch C
    New Bioeth; 2023 Mar; 29(1):24-36. PubMed ID: 35972296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Disease Underreporting Is Predicted by Country-Level Preparedness, Politics, and Pathogen Severity.
    Meadows AJ; Oppenheim B; Guerrero J; Ash B; Badker R; Lam CK; Pardee C; Ngoon C; Savage PT; Sridharan V; Madhav NK; Stephenson N
    Health Secur; 2022; 20(4):331-338. PubMed ID: 35925788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REVISITING HEALTH INFORMATION TECHNOLOGY ETHICAL, LEGAL, and SOCIAL ISSUES and EVALUATION: TELEHEALTH/TELEMEDICINE and COVID-19.
    Kaplan B
    Int J Med Inform; 2020 Nov; 143():104239. PubMed ID: 33152653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mandatory notification of infectious diseases and agents in Germany: development and suggestions for improvement].
    Heudorf U; Gottschalk R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jun; 63(6):777-789. PubMed ID: 32399605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data Privacy, Regulations and Legal Issues on COVID-19 Tracking Apps: A Scoping Review.
    Wongsin U; Wannasri A; Iqbal U; Chen TY
    Stud Health Technol Inform; 2022 Jan; 289():388-391. PubMed ID: 35062173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating the Delone and Mclean's model in a developing country's infectious disease pandemic context.
    Ikenyei U; Haggerty N
    BMC Infect Dis; 2024 Jun; 24(1):594. PubMed ID: 38886674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.